US Patent Issued to The Cleveland Clinic Foundation, Siemens Healthineers on Feb. 17 for "Molecular predictors of patient response to radiotherapy treatment" (German, Austrian, American Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,090, issued on Feb. 17, was assigned to The Cleveland Clinic Foundation (Cleveland) and Siemens Healthineers AG (Forchheim, Germany).

"Molecular predictors of patient response to radiotherapy treatment" was invented by Matthias Siebert (Marloffstein, Germany), Carsten Dietrich (Nuremberg, Germany), Heike Wehner (Bamberg, Germany), Jens-Christoph Georgi (Oberasbach, Germany), Mohamed Abazeed (Willowbrook, Ill.), Andreas Emanuel Posch (Vienna), Andreas Kappel (Glashuetten, Germany) and Mark Matzas (Nuremberg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods of predicting a radiotherapy success in a method of treating a lung...